Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
February 22 2017 - 6:30AM
Geron Corporation (Nasdaq:GERN) will announce its financial results
for the fourth quarter and year ended December 31, 2016, on
Wednesday, March 1, 2017, after the market close. Geron’s
management will also host a conference call for analysts and
investors on Wednesday, March 1, 2017, at 4:30 p.m. Eastern Time to
discuss the company’s fourth quarter and annual results as well as
recent events.
Participants can access the conference call live via telephone
by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The
conference ID is 53505663. If accessing the conference call by
telephone, please dial in at least 10 minutes early to minimize any
delay in joining the call. A live audio-only webcast is also
available through the Investors section of our website at
www.geron.com or at http://edge.media-server.com/m/p/ouvh9xwx. The
audio webcast of the conference call will be available for replay
approximately one hour following the live broadcast through April
1, 2017.
About Geron
Geron is a clinical stage biopharmaceutical company focused on
the collaborative development of a first-in-class telomerase
inhibitor, imetelstat, in hematologic myeloid malignancies. For
more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2024 to May 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From May 2023 to May 2024